20 May 2026
TAVI in aortic regurgitation with a dedicated valve - LIVE case
Summary
An 80-year-old male with chronic kidney disease, a history of colon cancer (2013), paroxysmal AF, and LAD PCI 2 weeks earlier presented with symptomatic severe type III AR. He had normal LV function, but early LV dilation. The mechanism of AR was a combination of primary and secondary causes (RC prolapse and root dilation), with a stable aneurysm of the ascending aorta (48 mm).
A 27 mm Trilogy valve was implanted via right femoral access, with right radial access as secondary access.Hemodynamics were assessed immediately using a pressure wire (Savvy-wire).
LIVE Educational Case from University Medical Centre - Mainz, Germany
Navigate the video by moving your mouse over the chapter icon in the toolbar
Key moments
- 22:01 - 24:26 - Valve presentation
- 38:01 - 49:50 - Locator positionning
- 53:16 - 54:58 - Valve deployment
- 32:30 - 35:47 - Savvy-wire
- 55:38 - 56:17 - Hemodynamic measurement
- 1:10:47 - 1:14:16 - Procedural analysis
Keywords: Aortic regurgitation, Trilogy 27 mm, Savvy-wire
Learning Objectives
- To review the indications for the treatment of pure native aortic regurgitation and criteria for the use of dedicated transcatheter heart valve devices
- To understand the key steps for procedural planning, including anatomical assessment, imaging strategy and device positioning
- To highlight the technical aspects of the procedure, including sinus location, leaflet anchoring and neo-commissural alignment
